These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 22223733)

  • 21. Leishmania major Infection-Induced VEGF-A/VEGFR-2 Signaling Promotes Lymphangiogenesis That Controls Disease.
    Weinkopff T; Konradt C; Christian DA; Discher DE; Hunter CA; Scott P
    J Immunol; 2016 Sep; 197(5):1823-31. PubMed ID: 27474074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mir-126 is a conserved modulator of lymphatic development.
    Kontarakis Z; Rossi A; Ramas S; Dellinger MT; Stainier DYR
    Dev Biol; 2018 May; 437(2):120-130. PubMed ID: 29550364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-126a Directs Lymphangiogenesis Through Interacting With Chemokine and Flt4 Signaling in Zebrafish.
    Chen J; Zhu RF; Li FF; Liang YL; Wang C; Qin YW; Huang S; Zhao XX; Jing Q
    Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2381-2393. PubMed ID: 27789478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble vascular endothelial growth factor receptor 3 is essential for corneal alymphaticity.
    Singh N; Tiem M; Watkins R; Cho YK; Wang Y; Olsen T; Uehara H; Mamalis C; Luo L; Oakey Z; Ambati BK
    Blood; 2013 May; 121(20):4242-9. PubMed ID: 23476047
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Slit2N and Robo4 regulate lymphangiogenesis through the VEGF-C/VEGFR-3 pathway.
    Yu J; Zhang X; Kuzontkoski PM; Jiang S; Zhu W; Li DY; Groopman JE
    Cell Commun Signal; 2014 Apr; 12():25. PubMed ID: 24708522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. VEGFR-3 signaling is regulated by a G-protein activator, activator of G-protein signaling 8, in lymphatic endothelial cells.
    Sakima M; Hayashi H; Mamun AA; Sato M
    Exp Cell Res; 2018 Jul; 368(1):13-23. PubMed ID: 29649427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mobilization of lymphatic endothelial precursor cells and lymphatic neovascularization in primary Sjögren's syndrome.
    Alunno A; Ibba-Manneschi L; Bistoni O; Rosa I; Caterbi S; Gerli R; Manetti M
    J Cell Mol Med; 2016 Apr; 20(4):613-22. PubMed ID: 26828975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuropilin-2 contributes to LPS-induced corneal inflammatory lymphangiogenesis.
    Tang X; Sun J; Du L; Du H; Wang L; Mai J; Zhang F; Liu P
    Exp Eye Res; 2016 Feb; 143():110-9. PubMed ID: 26500194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CPT1A regulates breast cancer-associated lymphangiogenesis via VEGF signaling.
    Xiong Y; Liu Z; Zhao X; Ruan S; Zhang X; Wang S; Huang T
    Biomed Pharmacother; 2018 Oct; 106():1-7. PubMed ID: 29940537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. VEGFR-3 ligand-binding and kinase activity are required for lymphangiogenesis but not for angiogenesis.
    Zhang L; Zhou F; Han W; Shen B; Luo J; Shibuya M; He Y
    Cell Res; 2010 Dec; 20(12):1319-31. PubMed ID: 20697430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential expression of VEGF ligands and receptors in prostate cancer.
    Woollard DJ; Opeskin K; Coso S; Wu D; Baldwin ME; Williams ED
    Prostate; 2013 May; 73(6):563-72. PubMed ID: 23038639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroblastoma progression correlates with downregulation of the lymphangiogenesis inhibitor sVEGFR-2.
    Becker J; Pavlakovic H; Ludewig F; Wilting F; Weich HA; Albuquerque R; Ambati J; Wilting J
    Clin Cancer Res; 2010 Mar; 16(5):1431-41. PubMed ID: 20179233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-182-5p inhibits colon cancer tumorigenesis, angiogenesis, and lymphangiogenesis by directly downregulating VEGF-C.
    Yan S; Wang H; Chen X; Liang C; Shang W; Wang L; Li J; Xu D
    Cancer Lett; 2020 Sep; 488():18-26. PubMed ID: 32473243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting VEGFR-3/-2 signaling pathways with AD0157: a potential strategy against tumor-associated lymphangiogenesis and lymphatic metastases.
    García-Caballero M; Paupert J; Blacher S; Van de Velde M; Quesada AR; Medina MA; Noël A
    J Hematol Oncol; 2017 Jun; 10(1):122. PubMed ID: 28629427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphatic MAFB regulates vascular patterning during developmental and pathological lymphangiogenesis.
    Dieterich LC; Tacconi C; Menzi F; Proulx ST; Kapaklikaya K; Hamada M; Takahashi S; Detmar M
    Angiogenesis; 2020 Aug; 23(3):411-423. PubMed ID: 32307629
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropilin-2 mediates VEGF-C-induced lymphatic sprouting together with VEGFR3.
    Xu Y; Yuan L; Mak J; Pardanaud L; Caunt M; Kasman I; Larrivée B; Del Toro R; Suchting S; Medvinsky A; Silva J; Yang J; Thomas JL; Koch AW; Alitalo K; Eichmann A; Bagri A
    J Cell Biol; 2010 Jan; 188(1):115-30. PubMed ID: 20065093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-VEGF-A therapy reduces lymphatic vessel density and expression of VEGFR-3 in an orthotopic breast tumor model.
    Whitehurst B; Flister MJ; Bagaitkar J; Volk L; Bivens CM; Pickett B; Castro-Rivera E; Brekken RA; Gerard RD; Ran S
    Int J Cancer; 2007 Nov; 121(10):2181-91. PubMed ID: 17597103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence of corneal lymphangiogenesis in dry eye disease: a potential link to adaptive immunity?
    Goyal S; Chauhan SK; El Annan J; Nallasamy N; Zhang Q; Dana R
    Arch Ophthalmol; 2010 Jul; 128(7):819-24. PubMed ID: 20625040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. S1PR1 regulates the quiescence of lymphatic vessels by inhibiting laminar shear stress-dependent VEGF-C signaling.
    Geng X; Yanagida K; Akwii RG; Choi D; Chen L; Ho Y; Cha B; Mahamud MR; Berman de Ruiz K; Ichise H; Chen H; Wythe JD; Mikelis CM; Hla T; Srinivasan RS
    JCI Insight; 2020 Jul; 5(14):. PubMed ID: 32544090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ADAMTS1 inhibits lymphangiogenesis by attenuating phosphorylation of the lymphatic endothelial cell-specific VEGF receptor.
    Inagaki J; Takahashi K; Ogawa H; Asano K; Faruk Hatipoglu O; Cilek MZ; Obika M; Ohtsuki T; Hofmann M; Kusachi S; Ninomiya Y; Hirohata S
    Exp Cell Res; 2014 May; 323(2):263-75. PubMed ID: 24631293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.